Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 3Gastrointestinal 1

Conditions

Colorectal Neoplasms 608Pancreatic Neoplasms 371Carcinoma, Hepatocellular 284Stomach Neoplasms 236Rectal Neoplasms 173Colonic Neoplasms 162Carcinoma, Non-Small-Cell Lung 160Esophageal Neoplasms 158Breast Neoplasms 138Neoplasms 126Neoplasm Metastasis 123Ovarian Neoplasms 114Lung Neoplasms 104Cholangiocarcinoma 101Liver Neoplasms 95Gastrointestinal Neoplasms 93Melanoma 82Biliary Tract Neoplasms 74Prostatic Neoplasms 71Esophageal Squamous Cell Carcinoma 66Endometrial Neoplasms 66Sarcoma 54Squamous Cell Carcinoma of Head and Neck 53Carcinoma, Renal Cell 53Uterine Cervical Neoplasms 47Adenocarcinoma Of Esophagus 45Head and Neck Neoplasms 44Urinary Bladder Neoplasms 39Triple Negative Breast Neoplasms 37Gastrointestinal Stromal Tumors 34

Interventions

folfirinox 1Taxes 1Oxaliplatin 1Leucovorin 1Irinotecan 1Gemcitabine 1Fluorouracil 1Erlotinib Hydrochloride 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Basal Cell × Gastrointestinal × 90 days × Clear all
NCT06483555 2026-04-23

PANGEA

UNC Lineberger Comprehensive Cancer Center

Phase 1/2 Recruiting
104 enrolled
DermatologicGastrointestinal

Pancreatic Neoplasms, Neoplasms, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡